AIVITA Highlights Ovarian Cancer Therapy at Cancer Stem Cell Conference 2016
IRVINE, Calif. – September 20, 2016 – AIVITA Biomedical today announced that it will present details on its autologous cancer immunotherapy,…
AIVITA CEO Comments on Recent Milestone Achievements in Asterias’ SCiStar Trial for Spinal Cord Injury
IRVINE, C.A., September 13, 2016 – AIVITA CEO and neuroscientist Dr. Hans Keirstead offered his congratulations today for milestones…
AIVITA Biomedical Awarded CIRM Grant for Development of 3D-Transplantable ‘Retinas’
IRVINE, C.A., July 7, 2016 – AiVita Biomedical, a Southern California-based therapeutic development company, today announced that the California…
AIVITA Biomedical Receives FDA Approval for Phase 2 Ovarian Cancer Treatment
IRVINE, C.A., June 21, 2016 – AIVITA Biomedical, a therapeutic development company focused on regenerative and curative medicines, today…
AIVita Biomedical Raises $2m in Series A Financing for Commercial and Clinical-Stage Program Development
IRVINE, C.A., June 10, 2016 — AIVITA Biomedical, a therapeutic development company focused on regenerative and curative medicines, today announced…